Quinazolinone derivatives as vanilloid antagonists

Details for Australian Patent Application No. 2006322186 (hide)

Owner Novartis AG

Inventors Ritchie, Timothy John; Culshaw, Andrew James; Brain, Christopher Thomas; Dziadulewicz, Edward Karol

Agent Davies Collison Cave

Pub. Number AU-A-2006322186

PCT Pub. Number WO2007/065663

Priority 0525069.1 08.12.05 GB

Filing date 6 December 2006

Wipo publication date 14 June 2007

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065663 Priority application(s): WO2007/065663

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322187-Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors

2006322185-Trisubstituted quinazolinone derivatives as vanilloid antagonists